# US 2005/0238735 A1 · Orals dosage Noni formulations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0238735 A1
- Document ID: US20050238735A1
- Status: Published application
- Kind: A1
- Application number: 10/345,098
- Filed: 2003-01-15
- Published: 2005-10-27
- Earliest claimed: 2001-04-12
- Assignees: Lifesmart Nutrition, Inc.
- Inventors: Trevor Page; Darald Donnell
- Web page: https://patentgrep.com/patent/US20050238735A1

## CPC

- A23G 3/46: containing dairy products
- A23G 3/48: containing plants or parts thereof, e.g. fruits, seeds, extracts (containing gums A23G3/42)
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 31/7004: Monosaccharides having only carbon, hydrogen and oxygen atoms
- A61K 36/48: Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K 36/746: Morinda
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A23G: COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The present invention provides a Noni extract formulation which reduces or eliminates the strong disagreeable Noni taste, while simultaneously increasing the efficiency of a Noni extract dose. In one aspect, a Noni extract is uniformly dispersed in a caramel composition having an insulin response enhancing amount of sugar. In another aspect, the caramel composition may include an effective amount of an invert sugar.

## Claims

### Claim 1

A Noni extract formulation comprising a chew base having a therapeutically effective amount of a Noni extract dispersed therein.

### Claim 2 (depends on 1)

The Noni formulation of claim 1, wherein the amount of Noni extract is from about 1% to about 25% w/w of the formulation.

### Claim 3 (depends on 2)

The Noni formulation of claim 2, wherein the amount of Noni extract is from about 5% to about 15% w/w of the formulation.

### Claim 4 (depends on 1)

The Noni formulation of claim 1, wherein the Noni extract is obtained from a member of the group consisting of Tahitian Noni plants, Hawaiian Noni plants, Samoan Noni plants, and mixtures thereof.

### Claim 5 (depends on 1)

The Noni formulation of claim 1, wherein the Noni extract is obtained from a Samoan Noni plant.

### Claim 6 (depends on 1)

The Noni formulation of claim 1, wherein the Noni extract includes a therapeutically effective amount of a polysaccharide.

### Claim 7 (depends on 6)

The Noni formulation of claim 6, wherein the amount of polysaccharide is from about 2% to about 5% w/w of the Noni extract.

### Claim 8 (depends on 6)

The Noni formulation of claim 6, wherein the amount of polysaccharide is about 3% w/w of the Noni extract.

### Claim 9 (depends on 1)

The Noni formulation of claim 1, wherein Noni extract includes a therapeutically effective amount of proxeronine.

### Claim 10 (depends on 9)

The Noni formulation of claim 9, wherein the amount of proxeronine is from about 0.1% to about 50% w/w of the Noni extract.

### Claim 11 (depends on 9)

The Noni formulation of claim 9, wherein the amount of proxeronine is about 5% w/w of the Noni extract.

### Claim 12 (depends on 1)

The Noni formulation of claim 1, wherein the chew base includes an effective amount of an invert sugar.

### Claim 13 (depends on 12)

The Noni formulation of claim 12, wherein the amount of invert sugar is from about 1% to about 20% w/w of the formulation.

### Claim 13 (depends on 13)

The Noni formulation of claim 13, wherein the amount of invert sugar is about 3% to 15% w/w of the formulation.

### Claim 14 (depends on 12)

The Noni formulation of claim 12, wherein the invert sugar comprises a mixture of dextrose and fructose.

### Claim 15 (depends on 14)

The Noni formulation of claim 14, wherein the dextrose and the fructose are each present in an amount of about 50% w/w of the invert sugar.

### Claim 16 (depends on 12)

The Noni formulation of claim 12, wherein the invert sugar is provided by rice syrup and includes a mixture of glucose and maltose.

### Claim 17 (depends on 16)

The Noni formulation of claim 16, wherein the amount of rice syrup is from about 15% to about 40% w/w of the formulation.

### Claim 18

A method of making a Noni extract formulation comprising the steps of:
a) preparing a chew base containing an effective amount of an invert sugar in a conventional manner in a heated liquid phase form;
b) partially cooling said heated liquid phase to a temperature at which Noni extract is stable;
c) adding a desired amount of Noni extract to said partially cooled liquid phase;
d) agitating said partially cooled liquid phase until the Noni extract is substantially uniformly dispersed therein; and
e) further cooling said partially cooled liquid phase to a solid thereby resulting in said Noni extract formulation.

### Claim 19 (depends on 18)

The method of claim 18, wherein the temperature of said partially cooled liquid caramel phase is between about 160° F. to about 220° F. at the time said Noni extract is added.

### Claim 20 (depends on 19)

The method of claim 19, wherein the temperature is from about 180° F. to 200° F.

### Claim 21 (depends on 18)

The method of claim 18, wherein the amount of Noni extract is from about 0.1% to 24% w/w of the Noni formulation.

### Claim 22 (depends on 18)

The method of claim 18, wherein the amount of Noni extract is from about 9% to 13% w/w of the Noni formulation.

### Claim 23 (depends on 18)

The method of claim 18, wherein the invert sugar is provided by an effective amount of rice syrup.

### Claim 24 (depends on 18)

The method of claim 18, further comprising the step of: dividing the Noni extract formulation into individual serving size portions.

### Claim 25

A method of increasing the efficacy of a Noni extract dose comprising the steps of:
a) distributing an amount of Noni extract into a chew composition containing an insulin level enhancing amount of sugar and an invert sugar; and
b) orally administering the composition.

### Claim 26 (depends on 25)

The method of claim 25, wherein the amount of invert sugar is from about 1% to about 20% w/w of the formulation.

### Claim 27 (depends on 25)

The method of claim 25, wherein the amount of invert sugar is about 3% to 15% w/w of the formulation.

### Claim 28 (depends on 25)

The method of claim 25, wherein the invert sugar comprises a mixture of dextrose and fructose.

### Claim 29 (depends on 25)

The method of claim 25, wherein the dextrose and the fructose are each present in an amount of about 50% w/w of the invert sugar.

### Claim 30 (depends on 25)

The method of claim 25, wherein the invert sugar is provided by rice syrup and includes a mixture of glucose and maltose.

### Claim 31 (depends on 30)

The method of claim 30, wherein the amount of rice syrup is from about 15% to about 40% w/w of the formulation.

### Claim 32 (depends on 25)

The method of claim 25, wherein the step of administering the composition is performed at a time when digestive juices in the upper gastrointestinal tract are at a minimum.

### Claim 33 (depends on 25)

The method of claim 25, wherein the chew composition is administered in a total dosage that is insufficient to increase upper gastro intestinal tract digestive action to a level which substantially inactivates one or more active agents in the Noni extract.

### Claim 34

A method of reducing or eliminating an undesirable taste caused Noni extract comprising the step of:
a) distributing the Noni extract into a chew composition containing a sufficient amount of invert sugar to reduce or eliminate any disagreeable taste caused by the Noni extract.

### Claim 35 (depends on 34)

The method of claim 34, wherein the amount of invert sugar is from about 1% to about 20% w/w of the formulation.

### Claim 36 (depends on 34)

The method of claim 34, wherein the amount of invert sugar is about 3% to 15% w/w of the formulation.

### Claim 37 (depends on 34)

The method of claim 34, wherein the invert sugar comprises a mixture of dextrose and fructose.

### Claim 38 (depends on 37)

The method of claim 37, wherein the dextrose and the fructose are each present in an amount of about 50% w/w of the invert sugar.

### Claim 39 (depends on 34)

The method of claim 34, wherein the invert sugar is provided by rice syrup and includes a mixture of glucose and maltose.

### Claim 40 (depends on 39)

The method of claim 39, wherein the amount of rice syrup is from about 15% to about 40% w/w of the formulation.

### Claim 41

A Noni extract formulation comprising a chew base having an insulin level enhancing amount of sugar and invert sugar, and a therapeutically effective amount of a Noni extract, wherein said invert sugar is present in an amount sufficient to reduce a disagreeable taste imparted by the Noni extract, and the formulation has a total dosage size that is insufficient to increase upper gastro intestinal tract digestive activity to a degree which substantially inactivates one or more active agents in the Noni extract.

### Claim 42

A Noni extract formulation comprising a chew base having an insulin level enhancing amount of sugar and invert sugar, and a therapeutically effective amount of a Noni extract.
